Trial Search Results
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a basis for incorporating the use of IMRT to treat anal cancer in future treatment protocols.
Stanford is currently not accepting patients for this trial.
Inclusion Criteria:Histologically confirmed diagnosis of squamous cell carcinoma of the
anus. Must be able to provide informed consent.
Exclusion Criteria:History of new malignancy since the time of treatment for anal cancer.
Ages Eligible for Study
30 Years - 70 Years
Genders Eligible for Study